Initial Experience with the Medtronic ADVANTAGE Valve Prosthesis in the Mitral Position - Clinical Outcome and Analysis of Complications

Abstract

Objective: The Medtronic ADVANTAGE prosthetic heart valve is a bileaflet mechanical heart valve which has two main design modifications. The prosthesis has an enlarged central orifice to improve blood flow characteristics and an asymmetric butterfly pivot recess with expanded outflow component designed to enhance the blood flow washing through the pivot region. This report summarizes the initial experience with 55 patients who underwent isolated mitral valve replacement. Methods: We prospectively followed 55 patients undergoing mitral valve replacement with the Medtronic ADVANTAGE prosthesis in a single center study. All patients were operated on via a median sternotomy and a left atrial approach. Results: The age of the patients at implant ranged from 42 years to 77 years with a mean of 61.8 years. Forty-five percent of the patients were male. Seventy-five percent of the patients were in NYHA functional class III or IV prior to valve replacement. The diameters of the implanted prostheses were as follows: 25 mm in 2 patients, 27 mm in 12 patients, 29 mm in 20 patients, and 31 mm in 21 patients. Coronary artery bypass grafting was performed with valve replacement in 16.4 % of patients and additional tricuspid repair in 10.9 %. After one year, 97.6 % and after two years 100 % of the included patients were in NYHA functional class I or II. All patients had Coumadin (warfarin) therapy postoperatively with a target INR range of 2.5 to 3.5, or 3.0 to 4.0. There were 4 thromboembolic events (7.3 %) in the early period and 2 late events (2.6 %). Episodes of valve thrombosis were not seen during the follow-up, which consisted of 76.5 patient years. The hemodynamic performance was favorable and within clinically acceptable ranges. The incidence of valve-related mortality and morbidity in this preliminary study was extremely low, indicating good clinical results comparable to those reported for other bileaflet valves. Conclusion: The ADVANTAGE valve is a safe and effective option for mitral valve replacement with a very low incidence of valve-related complications.

Key words

cardiovascular surgery - heart valve surgery - heart disease

References

• 1 Moffat-Bruce S D, Jamieson W R. Long-term performance of prostheses in mitral valve replacement.  J Cardiovasc Surg. 2004;  45 427-447
• 2 Khan S, Chaux A, Matloff J. et al . The St. Jude valve. Experience with 1000 cases.  Thorac Cardiovasc Surg. 1994;  108 1010-1020
• 3 Baudet E M, Puel V, McBride J T. Long-term results of valve replacement with the St. Jude Medical prosthesis.  J Thorac Cardiovasc Surg. 1995;  109 858-870
• 4 Fiore A C, Barner H B, Swartz M T, McBride L R, Labovitz A J, Vaca K J, Vrain J S, Grunkemeier G L, Kaiser G C. Mitral valve replacement: randomized trial of St. Jude and Medtronic Hall prostheses.  Ann Thorac Surg. 1998;  66 707-713
• 5 Remadi J P, Baron O, Roussel C, Bizouarn P, Habasch A, Despins P, Michaud J L, Duveau D. Isolated mitral valve replacement with St. Jude Medical prosthesis - long-term results: a follow-up of 19 years.  Circul. 2001;  103 1542-1545
• 6 Emery R W, Arom K B, Kshettry V R. et al . Decision-making in the choice of heart valve for replacement in patients aged 60 - 70 years: twenty-year follow-up of the St. Jude Medical aortic valve prosthesis.  J Heart Valve Dis. 2002;  11 (Suppl 1) S37-S44
• 7 Ikonomidis J S, Kratz J M, Crumbley A J, Stroud M R, Bradley S M, Sade R M, Crawford F A. Twenty-year experience with the St. Jude Medical mechanical valve prosthesis.  J Thorac Cardiovasc Surg. 2003;  126 2022-2031
• 8 Emery R W, Krogh C C, Arom K V, Emery A M, Benyo-Albrecht K, Joyce L D, Nicoloff D M. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.  Ann Thorac Surg. 2005;  79 776-782
• 9 Masters R G, Helou J, Pipe A L, Keon W J. Comparative clinical outcomes with the St. Jude Medical, Medtronic Hall and CarboMedics mechanical heart valves.  J Heart Valve Dis. 2001;  10 403-409
• 10 Shu M C, Gross J M, O'Rourke K K, Yoganathan A P. An integrated macro/micro approach to evaluating pivot flow within Medtronic ADVANTAGE bileaflet mechanical heart valve.  J Heart Valve Dis. 2003;  12 503-512
• 11 Saxena R, Lemmon J, Ellis J, Yoganathan A. An in vitro assessment by means of laser Doppler velocimetry of the medtronic advantage bileaflet mechanical heart valve hinge flow.  J Thorac Cardiovasc Surg. 2003;  126 90-98
• 12 Shu M C, O'Rourke K K, Coppin C M, Lemmon J D. Flow characterization of the ADVANTAGE and St. Jude Medical bileaflet mechanical heart valves.  J Heart Valve Dis. 2004;  13 814-822
• 13 Rosengart T K, O'Hara M, Lang S J. Outcome analysis of 245 CarboMedics and St. Jude valves at the same institution.  Ann Thorac Surg. 1998;  66 1684-1691
• 14 Thourani V H, Weintraub W S, Craver J M, Jones E L, Gott J P, Brown W M, Puskas J D, Guyton R A. Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery.  Ann Thorac Surg. 2000;  70 778-783